Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-489P is a human pseudogene related to U6 small nuclear RNA (snRNA). U6 snRNA is a critical and highly conserved non-coding RNA essential for the splicing of pre-mRNA as part of the spliceosome. Pseudogenes such as RNU6-489P arise from ancestral U6 snRNA genes but acquire mutations that prevent them from performing the canonical functions of their parental gene, most often due to loss of promoter or coding ability. While originally considered nonfunctional genomic relics, some pseudogenes can contribute to gene regulatory networks at the RNA level, for example by serving as decoys for microRNAs or being transcribed into non-coding RNAs that affect parental gene expression. However, RNU6-489P itself is not classified as a therapeutic target, receptor, enzyme, or transporter; it is not known to encode a protein and is generally not used as a biomarker or drug target. Its primary significance is as a member of the diverse family of pseudogenes in the human genome. Additional context: Pseudogenes can be processed or unprocessed. Processed pseudogenes often lack introns and lie dispersed in the genome. U6 snRNA genes are conserved and often present in multiple genomic copies and pseudogenes. Most pseudogenes, including RNU6-489P, have no known therapeutic relevance. There is no evidence of interacting drugs, drug mechanisms, biomarkers, or related safety concerns for this pseudogene in current scientific literature.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 489, pseudogene (RNU6-489P).